Copy to clipboard 
CaP Biomaterials announced a further expansion of its East Troy, Wisconsin manufacturing facility as the company celebrates its 20th anniversary. The investment includes doubling laboratory space, adding new analytical equipment, and expanding its biomaterials portfolio to include calcium sulfate.
The expansion builds on the company’s previous investments in its 20,000+ square-foot facility and reinforces its position as a US-based calcium phosphate development and contract manufacturing partner serving medical device OEMs. Operating under an ISO 13485:2016-certified quality management system, CaP supports programs from early R&D through commercial production, including batch sizes up to 600 kg.
The company’s story began in 2006 when a medical device manufacturer sought a reliable US source of synthetic hydroxyapatite and could not find one. The opportunity led Dr. Larry Shimp to establish CaP Biomaterials, drawing on decades of expertise in calcium phosphate science and biomaterials development.
Today, CaP’s cleanrooms, large-volume production capabilities, expanded laboratory, and ISO-certified quality system are designed to support long-term primary supplier relationships with medical device manufacturers.
“We are a no-nonsense contract manufacturing company, focused fully on meeting our customers’ needs,” said Onno Visser, Site Manager at CaP Biomaterials. “Over the last 20 years, CaP has been built with great care, and we pride ourselves on having knowledgeable and highly motivated staff with a deep understanding of what it takes to manufacture quality products, every batch, with great consistency.”
Source: CaP Biomaterials, LLC
